Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diterpene/krebs

Der Link wird in der Zwischenablage gespeichert
15 Ergebnisse

Monoterpenes, sesquiterpenes and diterpenes as cancer therapy

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION Treatment of human cancer is an area of clinical medicine which remains fraught with complications and which often presents an array of suboptimal treatment choices. For example, prostate cancer, which is the most common cancer in men and the second leading cause of

Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The present invention relates to a novel use of diterpene compounds as a therapeutic agent for the treatment of inflammatory disease, immunological disease or cancer. BACKGROUND OF THE INVENTION Exposure of human tissue or cells to harmful stimuli such as lipopolysaccharide

Use certain diterpene compounds in the treatment of androgen receptor-associated diseases

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION This invention relates to the use of certain types of diterpene compounds for inhibiting activities of androgen receptors and methods of using those compounds for treatment of androgen receptor-associated diseases, including prostate cancer, benign prostate hypertrophy,

Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION 1. Field of the Invention The present disclosure relates to novel use of compounds isolated from Euphorbia neriifolia for manufacturing a medicament or a pharmaceutical composition for treating cancer and/or thrombocytopenia. 2. Description of Related Art The leaves

Purified flavonoid and diterpene 5.alpha.-reductase inhibitors from thuja orientalis for androgen-related diseases

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to therapeutics of androgenetic diseases containing as active ingredients the nonsteroidal 5.alpha.-reductase inhibitors that have been obtained by fractioning the extracts of crude drugs including Thuja orientalis,
TECHNICAL FIELD This invention relates to a method of producing a taxane-type diterpene including taxol which is useful as a therapeutic agent for ovarian cancer, mammary cancer, lung cancer and the like, and a method of obtaining cultured cells which produce the taxane-type diterpene at a high
TECHNICAL FIELD This invention relates to a method of producing a taxane-type diterpene including taxol which is useful as a therapeutic agent for ovarian cancer, mammary cancer, lung cancer and the like, and a method of obtaining cultured cells which produce the taxane-type diterpene at a high

Treatment of prostate cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The present invention relates generally to chemical agents useful in treatment and prophylaxis of prostate cancer or a related cancer or condition or in the amelioration of symptoms resulting from or facilitated by prostate cancer or a related cancer or condition in a

Pimarane diterpenes from Anisochilus verticillatus

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a National Phase of PCT/IN2012/000544, filed 6 Aug. 2012, which claims priority from Indian Application No. 2226/DEL/2011, filed 5 Aug. 2011, the disclosures of which are all incorporated herein by reference. TECHNICAL FIELD OF

Tricyclic diterpene derivatives

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing
The invention concerns new antineoplastic preparations, as well as a process for the preparation of their active components. For therapeutic application are used antineoplastic preparations which are characterized in that they contain as an active antineoplastic component non- or slightly irritating

Topical use of ingenol-3-angelate or a salt thereof to treat skin cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate,

Derivatives of hypoestoxide and related compounds

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS REFERENCE TO RELATED APPLICATIONS Expressly incorporated herein by reference are U.S. Pat. Nos. 5,801,193, 5,994,328, 6,001,871 and 6,242,484, PCT WO 98/46222 and previously application, U.S. Ser. No. 09/298,653, now abandoned. BACKGROUND OF THE INVENTION Field of the Invention This invention

Method of use of diterpenoid derivatives as anticancer agents

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The present invention relates to a group of derivatives synthesized based on the ent-kaurane diterpenoid flexicaulin A and the methods to synthesize such diterpenoid derivatives. The invention also relates to the chemical entities of such synthetic diterpene compounds in the

Method of use of diterpenoid derivatives as anticancer agents

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The present invention relates to a group of derivatives synthesized based on the ent-kaurane diterpenoid flexicaulin A and the methods to synthesize such diterpenoid derivatives. The invention also relates to the chemical entities of such synthetic diterpene compounds in the
Treten Sie unserer
Facebook-Seite bei

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

  • Arbeitet in 55 Sprachen
  • Von der Wissenschaft unterstützte Kräuterkuren
  • Kräutererkennung durch Bild
  • Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
  • Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
  • Suchen Sie nach Heilkräutern nach ihrer Wirkung
  • Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen

Google Play badgeApp Store badge